Progress and prospects: Zinc-finger nucleases as gene therapy agents

Gene Therapy

Volumn 15, Issue 22, 2008, Pages 1463-1468

  Carroll, D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHEMOKINE RECEPTOR CCR5; DIHYDROFOLATE REDUCTASE; DROSOPHILA PROTEIN; HOX PROTEIN; INTERLEUKIN 2 RECEPTOR GAMMA; LENTIVIRUS VECTOR; LIGANDIN; NO TAIL PROTEIN; PROTEIN BW; PROTEIN GOLDEN; PROTEIN NW; PROTEIN RY; PROTEIN SURA; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VIRUS PROTEIN; ZEBRAFISH PROTEIN; ZINC FINGER PROTEIN;

BINDING AFFINITY; CLINICAL TRIAL; CYTOTOXICITY; DNA BINDING MOTIF; DNA FLANKING REGION; DNA MODIFICATION; DRUG MECHANISM; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE INSERTION; GENE REPLACEMENT THERAPY; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; HOMOLOGOUS RECOMBINATION; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

ANIMALS; ENDONUCLEASES; FORECASTING; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; ZINC FINGERS;

EID: 55549129245     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.145     Document Type: Review

References (22)

1. Cathomen T, Joung JK. Zinc-finger mideases: The next generation emerges. Mol Therapy 2008; 16: 1200-1207.
2. Porteus MH. Mammalian gene targeting with designed zinc finger nucleases. Mol Therapy 2006; 13: 438-446.
3. Santiago Y, Cban E, Liu P-Q, Orlando S, Mang L, Urnov FD et al. Targeted gene kickout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA 2008; 105: 5809-5814.
4. Lombardo A, Genovese P, Beausejour CM, Colleom S, Lee Y-L, Kim KA et al. Gene ediding in human stem cells using zinc finger nucleases and integrase-defective lentiviral. vector delivery. Nat Biotechnol 2007; 25: 1298-1306.
5. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26: 808-816.
6. Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M et al. Rapid 'Open-Source' engineering of customized zinc finger nucleases for highly efficient gerte modification. Mol Cell 2008; 31: 294-301.
7. Meng X, Noyes MB, Zhu LJ, Lawson ND, Wolfe SA. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol 2008; 26: 695-701.
8. Doyon Y, MaCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE et al Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 2008; 26: 702-708.
9. Moehle EA, Rock JM, Lee Y-L, Jouvenot Y, DeKelver RC, Gregory PD et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 2007; 104: 3055-3060.
10. Beumer K, Bhattacharyya G, Bibikova M, Trautman JK, Carroll D. Efficient gene targeting in Drosophila with zinc finger nucleases. Genetics 2006; 172: 2391-2403.
11. Morton J, Davis MW, Jorgensen EM, Carroll D. Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells. Proc Natl Acad Sci USA 2006; 103: 16370-16375.
12. Minczuk M, Papworth MA, Miller JC, Murphy MP, Klug A. Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA. Nucleic Acids Res 2008; 36: 3926-3938.
13. Szczepek M, Brondani V, Buchel J, Serrano L, Segal DJ, Cathomen T. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nature Biotechnol 2007; 25 786-793.
14. Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M, Joung JK et al. DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol Therapy 2008; 16: 352-358.
15. Pruett-Miller SM, Connelly JP, Maeder ML, Joung JK, Porteus MH. Comparison of zinc-finger nucleases for use in gene targeting in mammalian cells. Mol Therapy 2008; 16: 707-717.
16. Miller JC, Holmes MC, Wang J, Guschin DY, Lee Y-L, Rupniewski I et al An improved zinc-finger nuclease architecture for highly specific genome cleavage. Nature Biotechnology 2007; 25: 778-785.
17. Carroll D, Morton JJ, Beumer KJ, Segal DJ. Design, construction and in vitro testing of zinc finger nucleases. Nature Protocols 2006; 1: 1329-1341.
18. Mandell JG, Barbas III CF. Zinc Finger Tools: Custom DNAbinding domains for transcription factors and nucleases. Nucleic Acids Res 2006; 34: W516-W523.
19. Wright DA, Thibodeau-Beganny S, Sander JD, Wiinfrey RJ, Hirsh AS, Eichtinger M et al. Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly. Nat Protoc 2006; 1: 1637-1652.
20. Ramirez CL, Foley JE, Wright DA, Muller-Lerch F, Rahman SH, Cornu TI et al. Unexpected failure rates for modular assembly of engineered zinc fingers. Nat Methods 2008; 5: 374-375.
21. Paques F, Duchateau P. Meganucleases and DNA double-strand break-induced recombination: Perspectives for gene therapy. Curr Gene Ther 2007; 7: 49-66.
22. Calos MP. The phiC31 integrase system for gene therapy. Curr Gene Ther 2006; 6: 633-645.